Cart
sales@molnova.com
Lidocaine Hydrochloride hydrate
CAS No. 6108-05-0
Lidocaine Hydrochloride hydrate ( —— )
Catalog No. M15297 CAS No. 6108-05-0
Lidocaine, an amide local anesthetic, has anti-inflammatory properties in vitro and in vivo.
Purity : >98%(HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 50MG | 49 | In Stock |
|
| 100MG | 63 | In Stock |
|
| 200MG | 88 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameLidocaine Hydrochloride hydrate
-
NoteResearch use only, not for human use.
-
Brief DescriptionLidocaine, an amide local anesthetic, has anti-inflammatory properties in vitro and in vivo.
-
DescriptionLidocaine, an amide local anesthetic, has anti-inflammatory properties in vitro and in vivo, possibly due to an attenuation of pro-inflammatory cytokines, intracellular adhesion molecule-1 (ICAM-1), and reduction of neutrophils influx.
-
Synonyms——
-
PathwayAngiogenesis
-
TargetEGFR
-
RecptorEGFR; Sodium Channel
-
Research AreaCardiovascular Disease
-
Indication——
Chemical Information
-
CAS Number6108-05-0
-
Formula Weight288.82
-
Molecular FormulaC14H22N2O·HCl·H2O
-
Purity>98%(HPLC)
-
SolubilityDMSO: 10 mM
-
SMILESO.Cl.CCN(CC)CC(=O)NC1=C(C)C=CC=C1C
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Sheets PL, et al. J Physiol. 2007 Jun 15;581(Pt 3):1019-3
molnova catalog
related products
-
Beta-Hydroxyisovaler...
Beta-Hydroxyisovalerylshikonin is an inhibitor of protein-tyrosine kinases such as v-Src and EGFR, and has been shown to induce apoptosis in several human tumor cell lines. Beta-Hydroxyisovalerylshikonin significantly decreased viability of HCT116 cells (IC50 values = 30.9 μg/mL).
-
AZ5104
AZ5104, the demethylated metabolite of AZD-9291, is a potent EGFR inhibitor.
-
Dehydroabietic acid
Dehydroabietic acid (DAA) is an EBV-EA activation inhibitor.
